Barclays PLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.32 - $0.67 $16,317 - $34,165
-50,993 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$0.6 - $1.11 $8,771 - $16,227
-14,619 Reduced 22.28%
50,993 $31,000
Q3 2021

Nov 09, 2021
BUY
$1.01 - $1.82 $4,664 - $8,404
4,618 Added 7.57%
65,612 $68,000
Q2 2021

Aug 13, 2021
SELL
$1.39 - $2.21 $4,479 - $7,122
-3,223 Reduced 5.02%
60,994 $111,000
Q1 2021

May 13, 2021
BUY
$1.27 - $3.42 $81,555 - $219,622
64,217 New
64,217 $126,000
Q4 2020

Feb 11, 2021
SELL
$0.94 - $1.89 $9,051 - $18,198
-9,629 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$1.5 - $9.38 $40,254 - $251,721
-26,836 Reduced 73.59%
9,629 $17,000
Q2 2020

Aug 12, 2020
BUY
$4.79 - $8.39 $174,226 - $305,169
36,373 Added 39535.87%
36,465 $305,000
Q1 2020

May 13, 2020
SELL
$3.44 - $7.21 $55 - $115
-16 Reduced 14.81%
92 $0
Q4 2019

Feb 10, 2020
SELL
$4.29 - $5.64 $157,001 - $206,407
-36,597 Reduced 99.71%
108 $0
Q3 2019

Nov 14, 2019
SELL
$4.87 - $7.08 $171,862 - $249,853
-35,290 Reduced 49.02%
36,705 $179,000
Q2 2019

Aug 14, 2019
BUY
$6.6 - $7.8 $57,347 - $67,774
8,689 Added 13.73%
71,995 $499,000
Q1 2019

May 15, 2019
BUY
$5.76 - $8.95 $312,566 - $485,671
54,265 Added 600.21%
63,306 $440,000
Q4 2018

Feb 14, 2019
BUY
$5.26 - $7.97 $46,771 - $70,869
8,892 Added 5967.79%
9,041 $52,000
Q3 2018

Nov 14, 2018
SELL
$4.65 - $7.95 $49,987 - $85,462
-10,750 Reduced 98.63%
149 $1,000
Q2 2018

Aug 14, 2018
SELL
$5.05 - $6.8 $87,885 - $118,340
-17,403 Reduced 61.49%
10,899 $54,000
Q1 2018

May 15, 2018
BUY
$5.6 - $9.25 $111,535 - $184,232
19,917 Added 237.53%
28,302 $172,000
Q4 2017

Feb 14, 2018
SELL
$6.6 - $7.78 $129,465 - $152,612
-19,616 Reduced 70.05%
8,385 $60,000
Q3 2017

Nov 14, 2017
BUY
$5.75 - $7.75 $161,005 - $217,007
28,001
28,001 $200,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.62B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email